These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 25436903

  • 21. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE.
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [Abstract] [Full Text] [Related]

  • 22. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
    Attis MG, Burchette JL, Selim MA, Pham T, Soler AP.
    Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
    [Abstract] [Full Text] [Related]

  • 23. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population.
    Liu HG, Kong MX, Yao Q, Wang SY, Shibata R, Yee H, Martiniuk F, Wang BY.
    Head Neck Pathol; 2012 Dec; 6(4):401-8. PubMed ID: 22736149
    [Abstract] [Full Text] [Related]

  • 24. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM, Maier T, Besch R, Mestel DS, Ruzicka T, Sturm RA, Berking C.
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [Abstract] [Full Text] [Related]

  • 25. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes.
    Willis BC, Johnson G, Wang J, Cohen C.
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):109-12. PubMed ID: 25356946
    [Abstract] [Full Text] [Related]

  • 26. Utility of Sox10 labeling in metastatic breast carcinomas.
    Nelson ER, Sharma R, Argani P, Cimino-Mathews A.
    Hum Pathol; 2017 Sep; 67():205-210. PubMed ID: 28843711
    [Abstract] [Full Text] [Related]

  • 27. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C, Rochaix P, al Saati T, Valmary-Degano S, Boulinguez S, Launay F, Carle P, Lauwers F, Payoux P, Le Guellec S, Brousset P, Lamant L.
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [Abstract] [Full Text] [Related]

  • 28. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
    Karamchandani JR, Nielsen TO, van de Rijn M, West RB.
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
    [Abstract] [Full Text] [Related]

  • 29. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms.
    Cassarino DS, Su A, Robbins BA, Altree-Tacha D, Ra S.
    J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365
    [Abstract] [Full Text] [Related]

  • 30. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis.
    Ohtomo R, Mori T, Shibata S, Tsuta K, Maeshima AM, Akazawa C, Watabe Y, Honda K, Yamada T, Yoshimoto S, Asai M, Okano H, Kanai Y, Tsuda H.
    Mod Pathol; 2013 Aug; 26(8):1041-50. PubMed ID: 23558573
    [Abstract] [Full Text] [Related]

  • 31. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP, Smart C, Cassarino DS.
    Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
    [Abstract] [Full Text] [Related]

  • 32. Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology.
    Dermawan JKT, Underwood D, Policarpio-Nicolas ML.
    Diagn Cytopathol; 2019 Jul; 47(7):653-658. PubMed ID: 30794352
    [Abstract] [Full Text] [Related]

  • 33. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT, van Belle P, Elenitsas R, Elder DE.
    Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
    [Abstract] [Full Text] [Related]

  • 34. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
    Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA.
    Am J Pathol; 1986 May; 123(2):195-203. PubMed ID: 3518473
    [Abstract] [Full Text] [Related]

  • 35. SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
    Szumera-Ciećkiewicz A, Bosisio F, Teterycz P, Antoranz A, Delogu F, Koljenović S, van de Wiel BA, Blokx W, van Kempen LC, Rutkowski P, Christopher van Akkooi A, Cook M, Massi D, EORTC Melanoma Group.
    Eur J Cancer; 2020 Sep; 137():175-182. PubMed ID: 32781392
    [Abstract] [Full Text] [Related]

  • 36. KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics.
    Aung PP, Sarlomo-Rikala M, Lasota J, Lai JP, Wang ZF, Miettinen M.
    Am J Surg Pathol; 2012 Feb; 36(2):265-72. PubMed ID: 22067329
    [Abstract] [Full Text] [Related]

  • 37. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
    Rochaix P, Lacroix-Triki M, Lamant L, Pichereaux C, Valmary S, Puente E, Al Saati T, Monsarrat B, Susini C, Buscail L, Delsol G, Voigt JJ.
    Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
    [Abstract] [Full Text] [Related]

  • 38. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
    Clevenger J, Joseph C, Dawlett M, Guo M, Gong Y.
    Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
    [Abstract] [Full Text] [Related]

  • 39. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma.
    Kang Y, Pekmezci M, Folpe AL, Ersen A, Horvai AE.
    Mod Pathol; 2014 Jan; 27(1):55-61. PubMed ID: 23929265
    [Abstract] [Full Text] [Related]

  • 40. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A, Stefanato CM, Ghosn S, Bhawan J.
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.